Skip to Main Content
CKG
Home
Home
Home
TKG
Author details
Breadcrumb
Author Details
Full Name
Anthony J Costello
Affiliation
Royal Melbourne Hospital
ORCID
Career Start Year
1974
Papers
252
H Index
41
Expertise
CM4AI Collaborator
PMID
Paper Title
Journal Title
Published Year
36324049
Transferability of robotic console skills by early robotic surgeons: a multi-platform crossover trial of simulation training.
J Robot Surg
2023
36610996
A polygenic two-hit hypothesis for prostate cancer.
J Natl Cancer Inst
2023
36637213
Same day discharge for robot-assisted radical prostatectomy: a prospective cohort study documenting an Australian approach.
ANZ J Surg
2023
34480323
A review of simulation training and new 3D computer-generated synthetic organs for robotic surgery education.
J Robot Surg
2022
35435276
Molecular classification of hormone-sensitive and castration-resistant prostate cancer, using nonnegative matrix factorization molecular subtyping of primary and metastatic specimens.
Prostate
2022
35688680
Phase 2 Study of Neoadjuvant FGFR Inhibition and Androgen Deprivation Therapy Prior to Prostatectomy.
Clin Genitourin Cancer
2022
35813255
Defining Prostatic Vascular Pedicle Recurrence and the Anatomy of Local Recurrence of Prostate Cancer on Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography.
Eur Urol Open Sci
2022
34912070
Potency outcomes after robot-assisted radical prostatectomy.
Nat Rev Urol
2022
34993496
Genetic Factors Associated with Prostate Cancer Conversion from Active Surveillance to Treatment.
HGG Adv
2022
34108644
MSH2-deficient prostate tumours have a distinct immune response and clinical outcome compared to MSH2-deficient colorectal or endometrial cancer.
Prostate Cancer Prostatic Dis
2021
35475136
Surgical innovation revisited: A historical narrative of the minimally invasive "Agarwal sliding-clip renorrhaphy" technique for partial nephrectomy and its application to an Australian cohort.
BJUI Compass
2021
35474704
The utility of magnetic resonance imaging in prostate cancer diagnosis in the Australian setting.
BJUI Compass
2021
33678516
Ductal variant prostate carcinoma is associated with a significantly shorter metastasis-free survival.
Eur J Cancer
2021
33541309
A modified Delphi study to develop a practical guide for selecting patients with prostate cancer for active surveillance.
BMC Urol
2021
34766681
Articles on robotic surgery.
ANZ J Surg
2021
34766679
Robotics in Australian urology contemporary practice and future perspectives.
ANZ J Surg
2021
34322653
Loss of <i>SNAI2</i> in Prostate Cancer Correlates With Clinical Response to Androgen Deprivation Therapy.
JCO Precis Oncol
2021
34294073
Transcriptome sequencing and multi-plex imaging of prostate cancer microenvironment reveals a dominant role for monocytic cells in progression.
BMC Cancer
2021
34310033
The modified International Society of Urological Pathology system improves concordance between biopsy and prostatectomy tumour grade.
BJU Int
2021
31199504
Fractionated stereotactic body radiotherapy for up to five prostate cancer oligometastases: Interim outcomes of a prospective clinical trial.
Int J Cancer
2020
32579772
Use of prostate-specific membrane antigen positron-emission tomography/CT in response assessment following upfront chemohormonal therapy in metastatic prostate cancer.
BJU Int
2020
32807235
Detection of ctDNA in plasma of patients with clinically localised prostate cancer is associated with rapid disease progression.
Genome Med
2020
30772200
Prostatic nerve subtypes independently predict biochemical recurrence in prostate cancer.
J Clin Neurosci
2019
31769182
Why a robot took my bladder.
ANZ J Surg
2019
30248237
Late biochemical recurrence after radical prostatectomy is associated with a slower rate of progression.
BJU Int
2019
28922689
Changing face of robot-assisted radical prostatectomy in Melbourne over 12 years.
ANZ J Surg
2018
29964126
Ga-labeled Prostate-specific Membrane Antigen Ligand-positron-emission Tomography: Still Just the Tip of the Iceberg.
Urology
2018
30596026
Preparation of fluorescent in situ hybridisation probes without the need for optimisation of fragmentation.
MethodsX
2018
29661963
Obesity suppresses tumor attributable PSA, affecting risk categorization.
Endocr Relat Cancer
2018
29592867
Periprostatic fat tissue transcriptome reveals a signature diagnostic for high-risk prostate cancer.
Endocr Relat Cancer
2018
29316106
Robotic-assisted radical cystectomy with intracorporeal urinary diversion versus open: early Australian experience.
ANZ J Surg
2018
27431748
Routinely reported 'equivocal' lymphovascular invasion in prostatectomy specimens is associated with adverse outcomes.
BJU Int
2017
29033190
3D modelling of radical prostatectomy specimens: Developing a method to quantify tumor morphometry for prostate cancer risk prediction.
Pathol Res Pract
2017
28551452
Editorial Comment.
J Urol
2017
28887847
Fournier's gangrene in a man on empagliflozin for treatment of Type 2 diabetes.
Diabet Med
2017
27454454
The impact of the United States Preventive Services Task Force (USPTSTF) recommendations against prostate-specific antigen (PSA) testing on PSA testing in Australia.
BJU Int
2017
27503036
An online psychological intervention can improve the sexual satisfaction of men following treatment for localized prostate cancer: outcomes of a Randomised Controlled Trial evaluating My Road Ahead.
Psychooncology
2017
26812572
A urinary microRNA signature can predict the presence of bladder urothelial carcinoma in patients undergoing surveillance.
Br J Cancer
2016
26384467
Is there a place for cytoreduction in metastatic prostate cancer?
BJU Int
2016
26456743
Stimulation of the Neurovascular Bundle Results in Rhabdosphincter Contraction in a Proportion of Men Undergoing Radical Prostatectomy.
Urology
2016
26350758
Patterns-of-care and health economic analysis of robot-assisted radical prostatectomy in the Australian public health system.
BJU Int
2016
26643552
The impact of multidisciplinary team meetings on patient assessment, management and outcomes in oncology settings: A systematic review of the literature.
Cancer Treat Rev
2016
26389985
The urologist's role in multidisciplinary management of placenta percreta.
BJU Int
2016
27653089
Comparing nodal versus bony metastatic spread using tumour phylogenies.
Sci Rep
2016
27120785
Reduction in expression of the benign AR transcriptome is a hallmark of localised prostate cancer progression.
Oncotarget
2016
27569453
High-resolution Map of Somatic Periprostatic Nerves.
Urology
2016
27094971
Feasibility for active surveillance in biopsy Gleason 3Â +Â 4 prostate cancer: an Australian radical prostatectomy cohort.
BJU Int
2016
26938350
Prognosis of node-positive bladder cancer in 2016.
Minerva Urol Nefrol
2016
26972452
Validation of the novel International Society of Urological Pathology 2014 five-tier Gleason grade grouping: biochemical recurrence rates for 3+5 disease may be overestimated.
BJU Int
2016
24989960
Streamlining the assessment of haematuria: 3-year outcomes of a dedicated haematuria clinic.
ANZ J Surg
2015
1 - 50 of 252
Column Actions
Search
Recommended Authors
Zeyad R Schwen
Glickman Urological & Kidney Institute, Cleveland Clinic
Career Start Year
2013
Number of shared co-authors
4
Devin N Patel
university of california san diego School of Medicine
Career Start Year
2011
Number of shared co-authors
0
Michael A Liss
University of Texas Health San Antonio
Career Start Year
2008
Number of shared co-authors
7
Jonathan L Wright
University of Washington Medical Center
Career Start Year
2005
Number of shared co-authors
10
Amirali Salmasi
University of California San Diego
Career Start Year
2005
Number of shared co-authors
4
Shiva M Nair
University of Western Ontario
Career Start Year
2005
Number of shared co-authors
0
Edward Rowe
Bristol Urological Institute, Southmead Hospital
Career Start Year
2004
Number of shared co-authors
13
Bilal Chughtai
New York Presbyterian Hospital-Weill Cornell
Career Start Year
2004
Number of shared co-authors
1
Tim Dudderidge
University Hospital Southampton NHS Foundation Trust
Career Start Year
2002
Number of shared co-authors
14
John K Parsons
university of california san diego Moores Cancer Center
Career Start Year
2001
Number of shared co-authors
9
Declan Cahill
Royal Marsden Hospital NHS Trust
Career Start Year
1999
Number of shared co-authors
13
David Robert Siemens
Queen's University
Career Start Year
1996
Number of shared co-authors
6
Alan Thompson
The Royal Marsden NHS Foundation Trust
Career Start Year
1996
Number of shared co-authors
13
Omer Acar
University of Illinois at Chicago
Career Start Year
1996
Number of shared co-authors
0
Chris Ogden
The Royal Marsden Hospital NHS Foundation Trust
Career Start Year
1993
Number of shared co-authors
13
James N'Dow
University of Aberdeen
Career Start Year
1993
Number of shared co-authors
9
Alexandre R Zlotta
University Health Network, Princess Margaret Cancer Center, University of Toronto
Career Start Year
1993
Number of shared co-authors
16
Raymond S Lance
Washington State University Elson S. Floyd College of Medicine
Career Start Year
1992
Number of shared co-authors
9
Nicolas Mottet
Hospitalier Universitaire de Saint-Etienne
Career Start Year
1989
Number of shared co-authors
15
Philip Cornford
Liverpool University Hospitals
Career Start Year
1988
Number of shared co-authors
7
Armen Aprikian
McGill University Health Centre, McGill University
Career Start Year
1987
Number of shared co-authors
12
Theo M de Reijke
Amsterdam University Medical Centers, University of Amsterdam
Career Start Year
1987
Number of shared co-authors
10
Franz Recker
PolyClinic St. Moritz/Scuol
Career Start Year
1986
Number of shared co-authors
7
Bruce J Trock
Johns Hopkins University School of Medicine
Career Start Year
1984
Number of shared co-authors
15
Arnulf Stenzl
Eberhard Karls University of Tubingen
Career Start Year
1984
Number of shared co-authors
15
Joseph L Chin
University of Western Ontario
Career Start Year
1982
Number of shared co-authors
11
Eric J Bergstralh
Mayo Clinic
Career Start Year
1980
Number of shared co-authors
3
Keong Tatt Foo
Rutgers Cancer Institute of New Jersey
Career Start Year
1975
Number of shared co-authors
0
Hartwig Huland
Martini-Klinik Prostate Cancer Center, University Hospital-Hamburg-Eppendorf
Career Start Year
1971
Number of shared co-authors
13
Ian M Thompson
CHRISTUS Santa Rosa Hospital-Medical Center
Career Start Year
1956
Number of shared co-authors
23
row(s) 1 - 30 of 30
Collaborators
Niall M Corcoran
Royal Melbourne Hospital, The University of Melbourne
Co-authored papers
74
Christopher M Hovens
Royal Melbourne Hospital, The University of Melbourne
Co-authored papers
49
Declan G Murphy
Peter MacCallum Cancer Centre, University of Melbourne
Co-authored papers
42
Damien Bolton
University of Melbourne
Co-authored papers
15
Geoff Macintyre
CRUK Cambridge Institute, University of Cambridge
Co-authored papers
10
Mark Frydenberg
Monash University
Co-authored papers
7
Martin E Gleave
University of British Columbia
Co-authored papers
6
Natalie Kurganovs
Australian Prostate Cancer Research Centre Epworth
Co-authored papers
6
David A Brent
University of Pittsburgh School of Medicine
Co-authored papers
5
Declan G M Murphy
King's College London
Co-authored papers
4
John J McNeil
Co-authored papers
3
Ashutosh K Tewari
Co-authored papers
3
Roderick C N van den Bergh
St. Antonius Hospital
Co-authored papers
3
Marita P McCabe
Co-authored papers
3
David E Neal
University of Oxford, John Radcliffe Hospital
Co-authored papers
3
John Trachtenberg
University of Toronto, University Health Network
Co-authored papers
2
Christopher P Evans
University of California Davis
Co-authored papers
2
Antonio Finelli
Princess Margaret Cancer Centre, University Health Network and University of Toronto
Co-authored papers
2
Alastair D Lamb
University of Oxford
Co-authored papers
2
Anthony T Papenfuss
Co-authored papers
2
Anne Y Warren
Cambridge University Hospitals National Health Service Foundation Trust
Co-authored papers
2
Graham G Giles
Co-authored papers
2
Chol-Hee Jung
University of Melbourne
Co-authored papers
2
Monique J Roobol
Erasmus MC Cancer Institute, University Medical Center Rotterdam
Co-authored papers
2
Kevin So
Gladstone Institutes
Co-authored papers
1
Peter Van Loo
The Francis Crick Institute
Co-authored papers
1
Alan W Partin
The Brady Urological Institute, Johns Hopkins University School of Medicine
Co-authored papers
1
Vincent J Gnanapragasam
University of Cambridge
Co-authored papers
1
Natalie S Fox
University of California los angeles
Co-authored papers
1
Lawrence E Heisler
Ontario Institute for Cancer Research
Co-authored papers
1
1 - 30